Ladenburg Thalmann Financial Services’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
SCM
PIM
HAIM
HA
FWSM
LAM
ARM
Ladenburg Thalmann Financial Services's TRIB Position: Q2 2019 in Review
Ladenburg Thalmann Financial Services sold out of Trinity Biotech (TRIB) in Q2 2019, closing a stake of 60 shares — an estimated $1K sold.
Ladenburg Thalmann Financial Services first reported a position in TRIB in Q2 2013 and held it in 16 quarters. The position peaked at $139K in Q4 2013. 35 funds tracked by Wall St. Rank hold TRIB as of Q2 2019.
- Ladenburg Thalmann Financial Services reported no remaining Trinity Biotech position as of Q2 2019 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 60 Trinity Biotech shares in Q2 2019, an estimated $1K.
- Ladenburg Thalmann Financial Services first reported a position in Trinity Biotech in Q2 2013 and held it in 16 quarters.
- Ladenburg Thalmann Financial Services's Trinity Biotech position peaked at $139K in Q4 2013.
- 35 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2019, filed 15 Aug 2019.